HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Li-Zhe Wang Selected Research

Hepatoblastoma

5/2014Single-agent cisplatin treatment of children with high-risk hepatoblastoma.
7/2013[Preliminary study on the efficacy of irinotecan in the treatment of childhood relapsed hepatoblastoma].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Li-Zhe Wang Research Topics

Disease

2Neoplasm Metastasis (Metastasis)
12/2019 - 05/2014
2Hepatoblastoma
05/2014 - 07/2013
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2022
1Breast Neoplasms (Breast Cancer)
12/2019
1Osteosarcoma (Osteogenic Sarcoma)
12/2019
1Heart Failure
05/2014
1Neuroblastoma
02/2014
1B-Cell Lymphoma (Lymphoma, B Cell)
05/2012

Drug/Important Bio-Agent (IBA)

2Cisplatin (Platino)FDA LinkGeneric
12/2019 - 05/2014
1Biological ProductsIBA
12/2019
1Therapeutic UsesIBA
12/2019
1Doxorubicin (Adriamycin)FDA LinkGeneric
05/2014
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2014
1Topotecan (Hycamtin)FDA LinkGeneric
02/2014
1Vincristine (Oncovin)FDA LinkGeneric
02/2014
1Irinotecan (Camptosar)FDA LinkGeneric
07/2013
1Rituximab (Mabthera)FDA Link
05/2012

Therapy/Procedure

3Drug Therapy (Chemotherapy)
12/2019 - 05/2012
1APO protocol 2
01/2022
1Radiotherapy
12/2019
1Neoadjuvant Therapy
05/2014